...
首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.
【24h】

Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.

机译:在澳大利亚以人群为基础的猪孢子虫病监测:流行病学,疾病表现和金黄色葡萄球菌感染的出现。

获取原文
获取原文并翻译 | 示例

摘要

Australia-wide population-based surveillance for scedosporiosis identified 180 cases, with 118 (65.6%) cases of colonization and 62 (34.4%) cases of infection. Predisposing factors for isolation of Scedosporium spp. included chronic lung disease in 37.8% and malignancy in 21.7% of cases. Predictors of invasive disease (n=62) included haematological stem cell transplantation (n=7), leukaemia (n=16) and diabetes mellitus (n=8). Of 183 phenotypically-speciated isolates, 75 (41%) were Scedosporium prolificans (risk factors: haematologic cancer (n=17), neutropaenia (n=14)) and 108 (59%) had Scedosporium apiospermum/Pseudallescheria boydii phenotype [risk factor: diabetes (n=15)]. Scedosporium prolificans (p 0.01) and leukaemia (p 0.03) independently predicted death. Epidemiological and antifungal susceptibility profiles of Scedosporium aurantiacum (prevalence>or=15.8%) and S. apiospermum were similar. No patient with S. aurantiacum infection (n=6) died. This is the first description of clinical features associated with S. aurantiacum.
机译:在澳大利亚范围内的基于人群的血吸虫病监测中,确定了180例病例,其中定植的有118例(65.6%),感染的病例有62例(34.4%)。分离Scedosporium spp的诱因。包括慢性肺疾病占37.8%,恶性肿瘤占21.7%。侵袭性疾病的预测因子(n = 62)包括血液干细胞移植(n = 7),白血病(n = 16)和糖尿病(n = 8)。在183个表型特异性分离株中,有75个(41%)是产多孢假单胞菌(高危因素:血液系统癌症(n = 17),中性粒细胞减少症(n = 14)),有108个(59%)患有假单胞菌(Sedosporium apiospermum / Pseudallescheria boydii)[表型]。 :糖尿病(n = 15)]。产多孢子孢菌(p 0.01)和白血病(p 0.03)独立预测死亡。桔小孢子虫(Sedosporium aurantiacum)的流行病学和抗真菌药敏谱(患病率>或等于15.8%)和甜菜链霉菌相似。没有感染葡萄球菌的患者(n = 6)死亡。这是与金黄色葡萄球菌相关的临床特征的首次描述。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号